Functionally graded polymer knee implants for enhanced fixation,

By using polymer materials with porous structures and bioactive additives, combined with wear-resistant additives, knee implants are prepared, solving the problems of bone mineral density loss and unstable fixation in existing technologies. This achieves higher wear resistance and faster healing, and enhances the fixation effect of the implants.

CN121971698APending Publication Date: 2026-05-05EVONIK OPERATIONS GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610205964.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2018-02-02
Filing Date
2019-02-01
Publication Date
2026-05-05

AI Technical Summary

Technical Problem

Existing metal and ceramic knee implants can lead to problems such as bone mineral density loss, implant loosening, third body wear and mechanical failure during long-term use. In addition, traditional fixation methods have drawbacks such as micromotion, high complexity of revision, and poor biological response.

Method used

Using polymer materials with porous structures and bioactive additives, combined with wear-resistant additives, knee implants are prepared through additive manufacturing technology. This enhances bone adhesion and load transfer, promotes bone inward growth, and improves interfacial bonding.

Benefits of technology

It improves the wear resistance and bioresponsiveness of implants, reduces wear rate, extends service life, enhances fixation, promotes rapid healing, and reduces bone loss caused by stress shielding.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121971698A_ABST
    Figure CN121971698A_ABST
Patent Text Reader

Abstract

The invention relates to functionally graded polymeric knee implants for enhanced fixation, wear resistance and mechanical properties and manufacture thereof. The present invention includes polymer-based femoral and / or tibial component implants for total knee replacement / replacement procedures for providing improved wear resistance, enhanced physiological response at the bone / implant interface, and reduced stress shielding. The implant may be made via additive manufacturing. The articular surface of the implant may be implemented in the absence of any additive or in a form containing an additive for improving the tribological response. Furthermore, the instruments disclosed herein contain an interface surface (i.e., a bone / implant interface) in contact with natural bone, which may be present in its pure form, containing a bioactive additive. The implant has a porous topography on the bone / implant interface to improve biological response and improve fixation. Wherein the depth and topography of the additive is controlled via the techniques disclosed herein.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of the same invention patent application with application number 201980023197.1 and application date of February 1, 2019. Technical Field

[0002] This disclosure relates to devices for orthopedic implant applications, with the aim of providing implants with higher wear resistance, enhanced bone / implant interface osseointegration, reduced likelihood of third-body wear, rapid postoperative healing, and more effective load transfer from the implant to the natural bone structure, in an effort to reduce the detrimental effects of stress shielding on bone mineral density. The invention aims to improve the wear resistance of knee implant components and to induce physiological bonding at the interface between the knee implant and the natural ends of the distal femur and / or distal tibia. Background Technology

[0003] With an aging population, the demand for artificial implants is growing rapidly. Much of the focus in this field is on developing new technologies or modifying existing ones to provide improved materials and methods for large joint replacement / repair. Large joints include those belonging to the shoulder, hip, knee, and ankle, and unique systems are designed for each type of large joint to provide beneficial instruments to replace damaged, diseased, or dysfunctional natural structures.

[0004] While metal- and / or ceramic-based implants offer the enhanced mechanical properties required for large joint implants, they also come with drawbacks that can reduce their effectiveness, lifespan, and potentially cause adverse biological responses during daily activities such as walking, squatting, etc. For example, in total knee replacement surgery, CoCr femoral knee implants (along with other metal and / or ceramic implants) are commonly used because they are easy to polish to a smooth surface, provide adequate fixation to the natural bone, and offer reasonable wear resistance.

[0005] Although these metal and / or ceramic femoral knee implants dominate the overall knee replacement market (and hold the vast majority of the market share in other major joint reconstruction areas), their mechanical properties introduce a possibility that these materials could harm patient health with long-term use. While the mechanical properties and wear resistance of these types of materials are ideal, their mechanical properties exceeding those of natural bone are often a cause for concern.

[0006] Specifically, it has been shown that the improved mechanical properties of metal- and / or ceramic-based femoral knee implants consistently lead to a loss of bone mineral density in the distal femur. According to Wolff's Law, if natural bone is not subjected to a load, it will remodel and regenerate a modified structure according to the newly applied load. In the case of metal- and / or ceramic-based femoral knee implants, the implant bears the load typically applied to the distal femur, thus causing the distal femur to remodel accordingly, resulting in reduced bone mineral density. Subsequent concerns following this loss of bone mineral density, including the possibility of implant loosening, the occurrence of third-body wear, increased difficulty in revision procedures, and / or implant failure, must be addressed.

[0007] Furthermore, the problems with these metal- and / or ceramic-based implants are that they are radiopaque, have the potential to cause allergic reactions in patients, may release toxic substances into the patient's body, are susceptible to mechanically induced oxidation and corrosion, and have a history of mechanical failure due to these reasons and their tendency to migrate and detach from the initial fixation site due to a lack of long-term fixation to the distal femur. These numerous factors have led to the current paradigm shift towards the implementation of polymer-based materials in these specific applications. This shift in implant materials is attributed to the following factors: the mechanical properties of many polymer-based materials can be tuned to closely mimic the mechanical properties of natural bone, and their ease of processing, radiopaqueness, lack of allergic reactions in patients, and elimination of the potential for oxidation and corrosion of currently used metal-based implants. In addition, certain classes of polymer materials are bioinert, thus eliminating the possibility of any adverse systemic effects during implantation.

[0008] Of particular interest is the recent increase in the development of thermoplastic polymers such as polyaryletherketones (PAEKs) and their derivatives (i.e., polyetheretherketones, polyetherketones, polyetherketones, and other derivative polymers). While polyethylene and its derivatives (i.e., ultra-high molecular weight polyethylene, vitamin E-infused polyethylene, and cross-linked polyethylene) are commonly used in large joint reconstructions as surfaces to which implants can be joined, their use as femoral and / or tibial components in total knee replacement procedures has not received the same attention. Furthermore, recent studies have shown that wear debris particles from currently used polyethylene implants (e.g., tibial plates, acetabular liners, etc.) activate cellular processes that induce bone resorption via macrophage phagocytosis and subsequent cytokine secretion, ultimately leading to osteolysis. This process differs from the bone loss seen in stress shields associated with metal- and / or ceramic-based femoral implants, but ultimately results in the same outcome—implant loosening, loss of bone mineral density, and implant failure. Furthermore, if there is a loss of bone mineral density in the distal femur, the revision procedure becomes more difficult in the same way as stress shielding, resulting in less desirable survival rates for both the revision procedure and the subsequently revised implant during the patient's life.

[0009] A common problem associated with bone mineral density loss is securing the implant to the femur. Typically, the distal femur is removed to allow the femoral-knee implant to be fitted to the bone. Two types of femoral-knee implants have been used to ensure secure fixation: cemented and uncemented. Cemented fixation uses bone cement, typically polymethyl methacrylate (PMMA), at the bone / implant interface to minimize postoperative micromovement and migration. This type of fixation requires establishing a strong mechanical bond between the cement and bone, and between the cement and the implant. While initial fixation is sufficient for cemented techniques, micromovement has been observed in long-term studies. Some key factors to consider when choosing this approach include: third-body wear, extra-articular impingement, increased operative time, higher revision complexity, the possibility of bone thermal necrosis, and the potential for fat embolism during cement compression in the femoral canal. Because the bone cement commonly used is not bioabsorbable and does not degrade, its presence throughout the implant's lifespan continuously introduces the possibility of cement loosening and deposition between the joint surfaces, leading to premature implant failure. In contrast, cementless fixation relies on a surface morphology that facilitates bone growth. This approach typically involves modifications to the morphology (such as pores) and / or the application of a bioactive coating to the surface of the femoral-knee implant that contacts the distal femur. Advantages found in cementless implants compared to cemented implants include the physiological bonding of fixation as bone grows onto the implant, and long-term stability. While cementless implants may exhibit minor postoperative micromovements in the first three months, they typically stabilize after this time point and demonstrate equivalent or better survival rates compared to cemented techniques. Furthermore, this technique does not increase the complexity of revision procedures if necessary, as there is no residual cement between the bone and the implant that needs to be removed for implant replacement. Additionally, wear and tear on the articular surfaces of the femoral component of the knee implant occurs during the patient's daily activities (such as walking, squatting, etc.) and can lead to discomfort, bone damage, and eventual implant failure, which can be addressed by the inventions disclosed herein. Adding wear-resistant additives to the joint interface can improve the tribological properties of implants while maintaining a biologically favorable response and excellent mechanical properties.

[0010] Bone / implant interfaces are often prone to failure due to a lack of physiological bonding between the implant and the natural bone. This invention aims to improve the adhesion of such implants to natural bone via two platforms: (1) introducing a layer of bio-additives at the bone / implant interface, and / or (2) a porous morphology at the bone / implant interface containing micropores and / or macropores in an organized or non-organic manner. These techniques can be used independently or as a system and can induce and / or sustain inward bone growth at the bone / implant interface. Furthermore, the presence of physiologically driven bonding at the bone / implant interface can provide improved cross-interface load transfer compared to other currently employed techniques, such as cemented and / or uncemented femoral implants. In contrast to non-physiological bonding, physiological bonding at the bone / implant interface can lead to more efficient and relevant cross-interface load transfer, thereby enabling the bone to maintain its bone mineral density according to Wolff's law. Furthermore, the present invention has the potential to promote faster postoperative healing due to the presence of bio-additives and / or porous surfaces in the polymer matrix at the bone / implant interface, which can induce rapid bone inward growth. The joint surface of the implant comprises a polymer-based material in its native form or containing additives capable of improving wear resistance at the joint interface.

[0011] Key factors in choosing this technique include the necessity of good bone quality, the accuracy of pre-implantation osteotomy, and the issue of early post-operative micromovement. Furthermore, considering the surgical time, cement, and mixing equipment required for cemented techniques, it reduces the price increase per implant, which is often considered a disadvantage for this technique. While this cementless technique is more commonly used for tibial implants, its known benefits can provide enhanced fixation, load transfer, and biointegration in femoral-knee implants.

[0012] Recent efforts to improve implant-femoral fixation and load transfer have led to research into the implementation of porous structures at the bone / implant interface. This porosity at the bone / implant interface allows bone to grow inward into the implant, thus enhancing the overall stability and potential survival rate of the implant. Porous titanium has become a leading material choice for this specific application due to its widely reported positive response to bone inward growth. However, even in these types of porous Ti implants where bone inward growth may be sufficient, stress shielding issues remain and can lead to the same detrimental outcomes as currently used metal- and / or ceramic-based femoral-knee implants. Summary of the Invention

[0013] This invention relates to improving the wear resistance of knee implant components and inducing physiological bonding at the interface between the knee implant and the natural ends of the distal femur and / or distal tibia. Adding wear-resistant additives to the joint interface can improve the tribological properties of the implant while maintaining a biologically favorable response and excellent mechanical properties.

[0014] Furthermore, the present invention also relates to knee implants manufactured via additive manufacturing.

[0015] Furthermore, the present invention also relates to porous knee implants that provide improved biological response and improved fixation compared to non-porous knee implants.

[0016] Furthermore, the present invention also relates to porous knee implants having polymeric materials comprising PAEK types (PEEK, PEKK, PAKEKK, etc.).

[0017] Wear at the articular interface of orthopedic implants occurs during patients' daily activities after surgery and is addressed in the invention disclosed herein. The implementation of a low-wear polymer class and the introduction of wear-resistant additives into the same polymer matrix can provide a reduced wear rate, thereby extending lifespan and patient health. Reducing the wear rate by implementing a low-wear polymer class at the articular surface and / or compounding the same polymer class with fibers, particles, and / or combinations thereof therein also reduces the likelihood of wear debris generation and subsequent adverse biological responses. Furthermore, wear-resistant enhancements can be tuned to simultaneously modify the mechanical properties of the implant to more closely match the mechanical properties of natural bone, aiming to reduce stress shielding and thereby maintain bone mineral density in the bone near the implant.

[0018] Bone / implant interfaces are often prone to failure due to a lack of physiological bonding between the implant and the natural bone. This invention aims to improve the adhesion of such implants to natural bone via two platforms: (1) introducing a layer of bio-additives at the bone / implant interface, and / or (2) a porous morphology at the bone / implant interface containing micropores and / or macropores in an organized or non-organic manner. These techniques can be used independently or as a system and can induce and / or sustain inward bone growth at the bone / implant interface. Furthermore, the presence of physiologically driven bonding at the bone / implant interface can provide improved cross-interface load transfer into the femur and / or tibia compared to other currently employed techniques such as cemented and / or uncemented femoral implants. In contrast to non-physiological bonding, physiological bonding at the bone / implant interface can lead to more efficient and relevant cross-interface load transfer, thereby enabling the bone to maintain its bone mineral density according to Wolff's law. Furthermore, the present invention has the potential to promote faster postoperative healing because the presence of bio-additives and / or porous surfaces in the polymer matrix at the bone / implant interface can induce rapid bone inward growth.

[0019] This invention includes the following aspects: 1. A polymer-based knee implant comprising an articular surface and a bone / implant interface; wherein the bone / implant interface is porous; and wherein the implant has a polymer material comprising PAEK class (PEEK, PEKK, PEKEKK, etc.) or PE class (PE, HDPE, UHMWPE, XL-PE, Vit-E-PE).

[0020] According to aspect 1, the polymer-based knee implant has a porous bone / implant interface having a pore size of preferably 0.1 mm to 10 mm, more preferably 0.2 mm to 5 mm, and most preferably 0.3 mm to 1 mm.

[0021] According to aspect 1, the polymer-based knee implant contains a bioactive additive at the bone / implant interface.

[0022] According to aspect 1, the polymer-based knee implant comprises a highly abrasion-resistant bio-inert composition on the joint surface.

[0023] According to aspect 1, the polymer-based knee implant further includes a fixation pin.

[0024] The polymer-based knee implant according to aspect 1 comprises one or more components, wherein at least one component of the implant contains a bio-inert polymer.

[0025] According to aspect 1, the polymer-based knee implant, wherein one or more components comprise bioactive additives.

[0026] According to aspect 7, the polymer-based knee implant wherein the bioactive additive is a calcium phosphate derivative.

[0027] According to aspect 1, the polymer-based knee implant, wherein one or more components comprise a functional gradient layer of bioactive additives.

[0028] According to aspect 1, the polymer-based knee implant, wherein one or more components comprise a bioinert polymer, a bioactive additive, a osteoconductive additive, or any combination or mixture thereof.

[0029] According to aspect 1, a polymer-based knee implant, wherein one or more components comprise a bio-inert polymer, and wherein the bone / implant interface is porous.

[0030] According to aspect 1, the polymer-based knee implant comprises one or more components containing a bio-inert polymer, and the joint surface contains a wear-resistant additive.

[0031] According to aspect 1, the polymer-based knee implant, wherein one or more components comprise a functional gradient layer of wear-resistant additives.

[0032] According to aspect 1, the polymer-based knee implant contains a functional gradient layer of wear-resistant additives on the joint surface.

[0033] According to aspects 12 to 14, the polymer-based knee implants wherein the wear-resistant additive is carbon, glass, polymer wear-resistant additive, ceramic wear-resistant additive, metal wear-resistant additive, or any combination or mixture thereof.

[0034] According to aspect 1, in the polymer-based knee implant, one or more components comprise a bio-inert polymer, the joint surface comprises a wear-resistant additive, and the bone / implant interface comprises a bioactive additive, a osteoconductive additive, or any combination or mixture thereof.

[0035] According to aspect 1, the polymer-based knee implant comprises one or more components containing a bio-inert polymer, and the joint surface contains a wear-resistant additive.

[0036] According to aspect 1, the polymer-based knee implant comprises one or more components containing a bio-inert polymer and a bioactive additive, wherein the joint surface contains a wear-resistant additive.

[0037] The polymer-based knee implant according to aspect 1, wherein the implant contains a reinforcing additive.

[0038] According to aspect 19, the polymer-based knee implant, wherein the reinforcing additive is a fibrous material, a particulate material, or any combination or mixture thereof.

[0039] According to aspect 20, the polymer-based knee implant is wherein the fiber material is a carbon-based fiber material, a polymer fiber material, a glass, a ceramic fiber material, or any combination or mixture thereof.

[0040] According to aspect 21, the polymer-based knee implant is wherein the carbon-based fiber material is carbon fiber, pitch-derived carbon fiber, PAN-derived carbon fiber, or any combination or mixture thereof.

[0041] According to aspect 20, the polymer-based knee implant is wherein the particulate material is a polymer particulate material, a metal particulate material, a ceramic particulate material, or any combination or mixture thereof.

[0042] According to any of the foregoing aspects, the polymer-based knee implant is manufactured by blending, compounding, extrusion, injection molding, multi-component injection molding, co-injection molding, two-shot injection molding, injection-compression molding, compression molding, hot pressing, hot isostatic pressing, additive manufacturing, or a combination thereof.

[0043] According to aspect 1, the polymer-based knee implant is wherein the pores are created by sandblasting, salting out, matrix dissolution, additive manufacturing or a combination thereof, preferably by additive manufacturing.

[0044] According to aspect 25, the polymer-based knee implant is manufactured by additive manufacturing after blending a bio-inert polymer with a bioactive additive to form a blend material.

[0045] According to aspect 26, the polymer-based knee implant is manufactured by compounding the blended material into filaments using a twin-screw melt.

[0046] According to aspect 27, the polymer-based knee implant has the filament having a diameter of 1.5 mm to 3.25 mm.

[0047] According to aspect 27, the polymer-based knee implant contains up to about 20% by weight of the bioactive additive.

[0048] According to aspect 25, the polymer-based knee implant is printed via additive manufacturing at a printhead temperature of 380°C to 440°C.

[0049] According to aspect 25, the polymer-based knee implant is printed via additive manufacturing at a print bed temperature of 110°C to 160°C.

[0050] According to aspect 25, the polymer-based knee implant is printed via additive manufacturing at a printing speed of 10 mm / sec to 40 mm / sec.

[0051] According to any of the foregoing aspects, a polymer-based knee implant is wherein the implant is subjected to thermal annealing.

[0052] According to aspect 25, the polymer-based knee implant is wherein the annealing is performed at a temperature of 140°C to 250°C. Attached Figure Description

[0053] Some exemplary embodiments of the disclosed invention are shown as examples, but should not be construed as limiting the invention, wherein: Figure 1 A typical femoral knee joint implant is depicted, showing the joint surface 1 and the bone / implant interface surface 2.

[0054] Figure 2 A typical femoral knee joint implant is depicted, showing the articular surface 1, the bone / implant interface surface 2, and the studs 3, which are typically implemented to assist in the initial fixation of the implant.

[0055] Figure 3 A platform is described in which a porous bone / implant interface surface 4 is implemented from the bone / implant interface surface to a controlled thickness 5.

[0056] Figure 4 A platform is described in which a porous bone / implant interface surface 6 containing bioactive additives is implemented from the bone / implant interface surface to a controlled thickness 7.

[0057] Figure 5 A platform is described in which the wear-resistant composite joint surface 8 is implemented from the joint surface to a controlled thickness 9.

[0058] Figure 6 A platform is described in which a wear-resistant composite joint surface 8 is implemented from the joint surface to a controlled thickness 9, and a porous bone / implant interface surface 4 is implemented from the bone / implant interface surface to a controlled thickness 5.

[0059] Figure 7A platform is described in which a wear-resistant composite joint surface 8 is implemented from the joint surface to a controlled thickness 9, and a porous bone / implant interface surface 6 containing bioactive additives is implemented from the bone / implant interface surface to a controlled thickness 7.

[0060] Figure 8 A typical tibial footplate implant is depicted, showing a tibial support platform 10, a stabilizing wing 11, and a stabilizing column 12.

[0061] Figure 9 A typical tibial footplate implant is depicted, showing a tibial support platform 10 and a platform of the invention disclosed herein, which includes a surface porous stabilizing wing 13 and a surface porous stabilizing post 14.

[0062] Figure 10 A typical tibial plate implant is depicted, showing a platform of the invention disclosed herein, which includes a surface porous stabilizing wing 13, a surface porous stabilizing post 14, and a tibial support platform underside 15 containing surface pores.

[0063] Figure 11 A typical tibial plate implant is depicted, showing a tibial support platform 10 and a platform of the invention disclosed herein, which includes a surface porous stabilizing wing 16 containing bioactive additives and a surface porous stabilizing column 17 containing bioactive additives.

[0064] Figure 12 A typical tibial plate implant is depicted, showing a platform of the invention disclosed herein, which includes a surface porous stabilizing wing 16 containing bioactive additives, a surface porous stabilizing post 17 containing bioactive additives, and a tibial support platform underside 18 containing bioactive additives and surface pores.

[0065] Figure 13 A typical tibial footplate implant is depicted, showing a stabilizing wing 11, a stabilizing post 12, and a wear-resistant reinforced composite tibial support platform 19.

[0066] Figure 14 A typical tibial footplate implant is depicted, showing a wear-resistant reinforced composite tibial support platform 19 and a platform of the invention disclosed herein, which includes a surface-porous stabilizing wing 13 and a surface-porous stabilizing post 14.

[0067] Figure 15 A typical tibial plate implant is depicted, showing a wear-resistant reinforced composite tibial support platform 19 and a platform of the invention disclosed herein, which includes a surface-porous stabilizing wing 13, a surface-porous stabilizing post 14, and a lower side 15 of the tibial support platform containing surface pores.

[0068] Figure 16 A typical tibial footplate implant is depicted, showing a wear-resistant reinforced composite tibial support platform 19 and a platform of the invention disclosed herein, which includes a surface-porous stabilizing wing 16 containing bioactive additives and a surface-porous stabilizing column 17 containing bioactive additives.

[0069] Figure 17 A typical tibial plate implant is depicted, showing a wear-resistant reinforced composite tibial support platform 19 and a platform of the invention disclosed herein, which includes a surface porous stabilizing wing 16 containing bioactive additives, a surface porous stabilizing column 17 containing bioactive additives, and a tibial support platform underside 18 containing bioactive additives and surface pores.

[0070] Figure 18 A stable insert is depicted that secures the tibial footplate to the appropriate position within the tibia, showing the connection 20 with the tibial footplate and a typical bone / implant interface surface 21.

[0071] Figure 19 A stable insert is depicted that secures the tibial footplate to the appropriate position within the tibia, showing the connection 20 with the tibial footplate and the porous bone / implant interface surface 22.

[0072] Figure 20 A stable insert is depicted to fix the tibial footplate in the appropriate position within the tibia, showing the connection 20 with the tibial footplate and the porous bone / implant interface surface 23 containing bioactive additives.

[0073] Figures 21A, B, and C depict the compositional data of the polymeric materials containing the bioactive additive. Thermogravimetric analysis indicates that the bioactive additive constitutes approximately 20% by weight of the blend. The polymeric material shown is polyetheretherketone, and the bioactive additive is biphasic calcium phosphate (BCP)—a calcium phosphate derivative.

[0074] Figure 22 The average pore size of the samples was depicted, showing that small pores range from about 0.35 mm to about 0.5 mm, while large pores are defined as having an average size of about 0.55 mm to about 2 mm. Samples containing gradient pores are therefore a mixture of small and large pores, in such a way that a pore layer exists beneath a series of second, distinct pore layers.

[0075] Figure 23 The improvement in fixation observed in static load pull-out force analysis when using porous surfaces at the bone-implant interface is described.

[0076] Figure 24The increased flexural response until failure is depicted when tested under static compressive loads, provided a porous structure is imparted to the bone-implant interface. Detailed Implementation

[0077] The terminology used herein has been chosen for the purpose of describing particular embodiments of the invention and is not intended to limit the invention. In this document, the term “and / or” includes any and all combinations of one or more of the associated enumerated items. Furthermore, the terms “comprising” and / or “including” should be understood in this specification to specify the presence of the stated features, procedures, components, elements, geometries, and / or other characteristics, but do not preclude the presence and / or addition of one or more additional features, procedures, components, elements, geometries, and / or other characteristics.

[0078] Unless otherwise specified, all terms (including those that are scientific and / or technical terms) should be understood to have the same meaning as commonly understood by one of ordinary skill in the art of this invention. Furthermore, terms such as those of common attributes should be interpreted as having a meaning consistent with their meaning within the relevant technical and / or scope of this disclosure, and should not be interpreted in an overly formal sense if the term is not so explicitly defined herein.

[0079] In describing the invention disclosed herein, it should be understood that numerous techniques and / or steps are disclosed. Each of these techniques and / or steps has its own individual benefit and can also be used in combination with one or more of the other techniques and / or steps disclosed herein. Therefore, for clarity, this description will avoid unnecessarily repeating all possible combinations of these individual steps, but should not be construed as limiting the possible techniques and / or steps to fall within the scope of the invention and the claims.

[0080] Novel apparatuses, preferred (but not limiting) embodiments, composite material specifications, and methods for carrying out the invention are discussed herein. In the following description, specific details are set forth for purposes of explanation in order to provide a thorough understanding of the invention. However, it will be apparent to those skilled in the art that the invention can be practiced without these specific details.

[0081] The disclosure herein is to be considered merely as an example of the invention and should not be construed as limiting the invention to the specific embodiments shown in the description and drawings herein.

[0082] The invention will now be described with reference to the accompanying drawings, which represent preferred embodiments but do not limit the potential embodiments of the invention.

[0083] Figure 1A typical femoral knee joint implant is depicted, with the joint surface 1 and the bone / implant interface surface 2 shown. Figure 2 A second possible implementation of a typical femoral implant is shown, featuring an articular surface 1 and a bone / implant interface 2, as illustrated, along with fixation pins 3 typically used to assist in the initial fixation of the implant. In these implementations, the articular surface 1 typically experiences the highest rate of wear in the implant because it engages the opposing tibial components during daily activities. The bone / implant interface 2 is typically secured to the distal femur using fixation pins 3 and / or bone cement (typically PMMA). This fixation provides adequate initial fixation, but its failure is known through long-term studies of the implant.

[0084] Figure 3 One possible embodiment of the invention is depicted, which illustrates an articular surface 1 and a porous bone / implant interface 4 having a controlled pore thickness 5 measured from the bone / implant interface. The introduction of the porous bone / implant interface 4 enables faster inward bone growth and subsequent long-term fixation without the use of stapes or bone cement, thereby eliminating potential stress concentration zones and potential third-body wear particles, respectively. Furthermore, the controlled pore thickness 5 allows for enhanced physiological responses from natural bone without affecting the articular surface 1 and thus without compromising wear resistance.

[0085] Figure 4 A porous bone / implant interface 6 containing bioactive additives is further described, featuring controlled pore thickness and bioactive additive permeability 7 as measured from the bone / implant interface. The introduction of the porous bone / implant interface 6 containing bioactive additives enables faster bone ingrown growth and subsequent long-term fixation without the use of stapes or bone cement, thereby eliminating potential stress concentration zones and potential third-body wear particles, respectively. Furthermore, the controlled pore thickness and bioactive additive permeability 7 allow for enhanced physiological responses from natural bone without affecting the articular surface 1 and thus without compromising wear resistance.

[0086] Figure 5 A modified typical femoral knee joint implant is depicted. In this particular embodiment, the bone / implant interface 2 remains as it is in the typical femoral knee joint implant. However, the joint surface contains wear-resistant additives 8 to a controlled depth 9 measured from the joint surface. The presence of these wear-resistant additives can improve the wear rate of the joint interface of the femoral knee joint implant and result in an extended implant lifespan.

[0087] Figure 6A femoral knee implant is described, comprising a porous bone / implant interface 4 with a controlled pore depth 5 and a wear-resistant additive-reinforced joint surface 8 with a controlled wear-resistant additive depth 9. This particular embodiment benefits from the porous bone / implant interface 4, which facilitates initial and long-term fixation of the implant, and from the wear-resistant additive 8 at the joint surface, which increases the lifespan of the implant.

[0088] Figure 7 Further possible embodiments of the invention are depicted, including a porous bone / implant interface 6 containing a bioactive additive having a controlled pore thickness and bioactive additive permeability 7 measured from the bone / implant interface. The introduction of the porous bone / implant interface 6 containing the bioactive additive enables faster inward bone growth and subsequent long-term fixation without the use of embolic screws or bone cement, thereby eliminating potential stress concentration zones and potential third-body wear particles, respectively. Furthermore, adding a wear-resistant additive 8 to a controlled depth 9 measured from the joint interface at the joint surface can result in a more wear-resistant composite material at the joint surface. Compared to currently employed techniques, this particular embodiment can lead to superior bone response and wear resistance, thereby significantly increasing implant survival rates.

[0089] Figure 8 A typical tibial insert for total knee arthroplasty is depicted, comprising a tibial plate 10, a stabilizing wing 11, and a stabilizing post 12. The tibial plate 10 is typically used to secure material that engages with the articular surface of the femoral assembly in place.

[0090] Figure 9 Another possible embodiment of this application is depicted, which includes a stabilizing wing 13 with surface porosity and a stabilizing column 14 with surface porosity. Furthermore, Figure 10 The bone / implant interface 15 of the tibial plate with implemented surface porosity is shown. The surface porosity present on the stabilizing wing 13, stabilizing post 14 and the underside of the tibial plate 15 can induce a more effective bone response when placed close to the tibia after implantation, resulting in stronger physiological bonding and subsequently increasing implant survival.

[0091] Figure 11 Another possible embodiment of this application is depicted, which includes a stabilizing wing 16 with surface pores containing bioactive additives and a stabilizing column 17 with surface pores containing bioactive additives. Furthermore, Figure 12 The bone / implant interface 18 of a tibial plate with implemented surface pores containing bioactive additives is shown. The surface pores and bioactive additives present on the stabilizing wing 16, stabilizing post 17 and underside of the tibial plate 18 can induce a more effective bone response when placed close to the tibia after implantation, resulting in stronger physiological bonding and subsequently increasing implant survival.

[0092] Figure 13 A typical tibial insert for total knee arthroplasty is depicted, comprising a stabilizing wing 11 and a stabilizing post 12. Furthermore, a tibial footplate 19 containing wear-resistant additives is introduced. The introduction of the tibial footplate containing wear-resistant additives can promote greater wear resistance of the tibial footplate and lead to an extended implant lifespan.

[0093] Figure 14 Another possible embodiment of this application is depicted, which includes a stabilizing wing 13 with surface porosity, a stabilizing post 14 with surface porosity, and a tibial plate containing wear-resistant additives. Furthermore, Figure 15 The bone / implant interface 15 of a tibial plate containing wear-resistant additive 19 with implemented surface porosity is shown. The surface porosity present on the stabilizing wing 13, stabilizing post 14 and the underside 15 of the tibial plate can induce a more effective bone response when placed close to the tibia after implantation, resulting in stronger physiological bonding and subsequently increasing implant survival.

[0094] Figure 16 Another possible embodiment of this application is depicted, which includes a stabilizing wing 16 with surface pores containing bioactive additives, a stabilizing post 17 with surface pores containing bioactive additives, and a tibial plantar plate containing wear-resistant additives. Furthermore, Figure 17 The bone / implant interface 18 of a tibial plate containing wear-resistant additive 19 with implemented surface pores and containing bioactive additives is shown. The surface pores and bioactive additives present on the stabilizing wing 16, stabilizing post 17 and the underside of the tibial plate 18 can induce a more effective bone response when placed close to the tibia after implantation, resulting in stronger physiological bonding and subsequently increasing implant survival.

[0095] Figure 18 A tibial insert, typically used for further stabilization of the tibial footplate, is depicted, having a connection 27 to the tibial footplate and a bone / implant interface surface 28.

[0096] Figure 19 One possible embodiment of the invention is depicted, comprising a connection 27 with the tibial footplate and a porous surface at the bone / implant interface 29. The surface porosity present at the bone / implant interface 29 of the tibial insert can induce a more effective bone response when placed close to the tibia after implantation, resulting in stronger physiological integration and subsequently increasing implant survival.

[0097] Figure 20One possible embodiment of the invention is depicted, comprising a connection 27 with the tibial footplate and a porous surface containing a bioactive additive at the bone / implant interface 30. The surface porosity and bioactive additive present at the bone / implant interface 30 of the tibial insert can induce a more effective bone response when placed close to the tibia after implantation, resulting in stronger physiological bonding and subsequently increasing implant survival.

[0098] Figure 21 depicts the compositional data of the polymer material containing the bioactive additive. Thermogravimetric analysis (Figure 21A) indicates that the bioactive additive constitutes approximately 20% by weight of the blend. The polymer material shown is polyetheretherketone, while the bioactive additive is biphasic calcium phosphate (BCP)—a calcium phosphate derivative. The relative amounts of carbon, oxygen, calcium, and phosphate in the chemical composition are also shown as results from energy-dispersive X-ray spectroscopy (Figures 21B and 21C) to verify the chemical composition and presence of the bioactive additive BCP.

[0099] Figure 22 The average pore size of the samples was depicted, showing that small pores range from approximately 0.350 mm to approximately 0.500 mm, while large pores are defined as having an average size of approximately 0.550 mm to approximately 2 mm. Samples containing gradient pores are therefore a mixture of small and large pores, in such a way that a pore layer exists beneath a second, distinct pore layer.

[0100] Figure 23 The improvement in fixation observed in static load pull-out force analysis when using porous surfaces at the bone-implant interface is described.

[0101] Figure 24 The increased flexural response until failure is depicted when tested under static compressive loads, provided a porous structure is imparted to the bone-implant interface.

[0102] Polymer-based knee implants include an articular surface and a bone / implant interface. Preferably, the implant also includes fixation pins.

[0103] The bone / implant interface is porous. The bone / implant interface has a pore size preferably from 0.1 mm to 10 mm, more preferably from 0.2 mm to 5 mm, and most preferably from 0.3 mm to 1 mm. Preferably, the pore size is determined by electron microscopy (preferably SEM) or optical microscopy. Small pores are defined in the range of about 0.35 mm to about 0.5 mm, while large pores are defined as having an average size of about 0.55 mm to about 2 mm.

[0104] Preferably, the bone / implant interface has gradient porosity. Preferably, the gradient porosity is a mixture of small and large pores, preferably in such a way that a pore layer exists beneath a series of second, different pore layers.

[0105] Preferably, the joint surface comprises a highly wear-resistant bio-inert composition.

[0106] Preferably, the implant comprises one or more components, and more preferably at least one component contains a bio-inert polymer. Preferably, at least one or more components contain a bioactive additive.

[0107] Suitable bioinert polymers include, but are not limited to, PAEKs (PEEK, PEKK, PEKEKK, etc.) or PEs (PE, HDPE, UHMWPE, XL-PE, Vit-E-PE).

[0108] Preferably, the bioactive additive is a phosphate derivative, more preferably apatite and calcium phosphate, and more preferably, the apatite comprises hydroxyapatite and fluorohydroxyapatite. The phosphate preferably comprises α- and / or β-tricalcium phosphate. The bioactive additive may also include a osteoconductive additive. Osteoconductive additives are additives that can promote bone growth.

[0109] Appropriately, bioactive materials are those that elicit specific biological responses at the material interface, leading to the formation of bonds between the tissue and the polymer material.

[0110] Preferably, one or more components of the implant contain a functional gradient layer of bioactive additives.

[0111] Preferably, one or more components of the implant comprise a bioinert polymer, a bioactive additive, a osteoconductive additive, or any combination or mixture thereof. Preferably, one or more components of the implant comprise a bioinert polymer, wherein the bone / implant interface is porous. Preferably, one or more components of the implant comprise a bioinert polymer, wherein the joint surface comprises a wear-resistant additive.

[0112] Preferably, one or more components of the implant include a functional gradient layer of abrasion-resistant additives.

[0113] Preferably, the joint surface comprises a functionally graded layer of wear-resistant additives. Preferably, the wear-resistant additives are carbon, glass, polymer wear-resistant additives, ceramic wear-resistant additives, metal wear-resistant additives, or any combination or mixture thereof.

[0114] Preferably, one or more components of the implant comprise a bioinert polymer, wherein the joint surface comprises a wear-resistant additive, and wherein the bone / implant interface comprises a bioactive additive, a osteoconductive additive, or any combination or mixture thereof. Preferably, one or more components of the implant comprise a bioinert polymer, wherein the joint surface comprises a wear-resistant additive, and wherein the bone / implant interface is porous. Preferably, one or more components of the implant comprise a bioinert polymer and a bioactive additive, wherein the joint surface comprises a wear-resistant additive, and wherein the bone / implant interface is porous.

[0115] Preferably, the implant includes a reinforcing additive. Preferably, the reinforcing additive is a fibrous material, a particulate material, or any combination or mixture thereof.

[0116] Preferably, the fiber material is a carbon-based fiber material. More preferably, the fiber material is carbon fiber, pitch-derived carbon fiber, PAN-derived carbon fiber, or any combination or mixture thereof.

[0117] Preferably, the fibrous material is a polymer fiber material, glass, ceramic fiber material, or any combination or mixture thereof. Preferably, the particulate material is a polymer particulate material, metal particulate material, ceramic particulate material, or any combination or mixture thereof.

[0118] Preferably, the implant is manufactured by blending, compounding, extrusion, injection molding, multi-component injection molding, co-injection molding, two-shot injection molding, injection-compression molding, compression molding, hot pressing, hot isostatic pressing, additive manufacturing, or a combination thereof.

[0119] Preferably, the pores of the porous knee implant are manufactured by sandblasting, salting out, matrix dissolution, additive manufacturing, or a combination thereof, and more preferably by additive manufacturing.

[0120] Preferably, the implant is manufactured by additive manufacturing after blending a bio-inert polymer with a bioactive additive to form a blend material.

[0121] Preferably, the blend is obtained by melt compounding in a twin-screw extruder to form filaments. Preferably, the filaments have a diameter of 1.5 mm to 3.25 mm. Preferably, the filaments contain up to about 20% by weight of the bioactive additive.

[0122] Preferably, the polymer-based knee implant is printed via additive manufacturing at a printhead temperature of 380°C to 440°C. Preferably, the implant is printed via additive manufacturing at a print bed temperature of 110°C to 160°C. Preferably, the implant is printed via additive manufacturing at a print speed of 10 mm / sec to 40 mm / sec.

[0123] Preferably, the implant is subjected to thermal annealing, preferably at a temperature of 140°C to 250°C.

[0124] In a preferred embodiment, the polymeric material used for the device is one of polyaryletherketone (PAEK polymers, including but not limited to PEEK, PEKK, PAKEKK and other polymers of the PAEK parent class, consisting of a backbone of alternating ether and ketone bonds with or without crosslinked polymer chains), polyetheretherketone (PEEK, poly-ether-ether-ketone and other embodiments of the parent polymer PAEK, with or without crosslinked polymer chains), polyethylene (PE, UHMWPE, crosslinked PE, vitamin E-infused PE and other embodiments and compounds of the parent polymer), and / or other biologically advantageous and mechanically robust polymers.

[0125] In a preferred embodiment, polymeric materials, including but not limited to polyaryletherketones (PAEK polymers, including but not limited to PEEK, PEKK, PAKEKK and other polymers of the PAEK parent material, consisting of a backbone of alternating ether and ketone bonds with or without crosslinked polymer chains), polyetheretherketones (PEEK, poly-ether-ether-ketone and other embodiments of the parent polymer PAEK, containing or without crosslinked polymer chains), polyethylene (PE, UHMWPE, crosslinked PE, vitamin E-infused PE and other embodiments and compounds of the parent polymer), and / or other biologically advantageous and mechanically robust polymeric materials, are present as the primary material in the device. Reinforcing fibers, including but not limited to carbon fibers (pitch-based carbon fibers and PAN-based carbon fibers), glass fibers, polymer fibers and / or ceramic fibers, may be present in the polymer matrix of the device as a means of enhancing and improving biological response.

[0126] In a preferred embodiment, polymeric compounds, including but not limited to polyaryletherketones (PAEK polymers, including but not limited to PEEK, PEKK, PAKEKK and other polymers of the PAEK parent compound, consisting of a backbone of alternating ether and ketone bonds with or without crosslinked polymer chains), polyetheretherketones (PEEK, poly-ether-ether-ketone and other embodiments of the parent polymer PAEK, containing or without crosslinked polymer chains), polyethylene (PE, UHMWPE, crosslinked PE, vitamin E-infused PE and other embodiments and compounds of the parent polymer), and other biologically advantageous and mechanically robust polymeric compounds, are present as a major component in the device. Reinforcing particles, including but not limited to carbon particles (asphalt-based carbon particles and PAN-based carbon particles), glass particles, metal particles, ceramic particles, and / or any combination thereof, may be present in the polymer matrix of the device as a means of enhancing mechanical and abrasion resistance as well as enhancing biological response.

[0127] Preferably, the polymer does not contain any polyethylene (PE, UHMWPE, cross-linked PE, vitamin E-infused PE, and other embodiments and compounds of the parent polymer).

[0128] In a preferred embodiment, the device is manufactured via a thermal method. These methods include, but are not limited to, compression molding, injection molding, additive manufacturing, or any combination thereof. As an example, but not a manufacturing limitation, pure / virgin or additive-containing polymers can be forcibly injected into a mold designed for a specific application geometry. In contrast, pure / virgin or additive-containing polymers can be extruded or otherwise thermally mixed and forced through a die, subsequently placing the molten material in the mold and shaping it.

[0129] The following examples are provided to provide those skilled in the art with a complete disclosure and description of how to prepare and evaluate the compositions, articles, apparatus, and / or methods claimed herein, and are intended purely as examples of the invention and not to limit the scope of what the inventors consider to be their invention. Efforts have been made to ensure accuracy regarding figures (e.g., quantities, temperatures, etc.), but some errors and deviations should be accounted for. Unless otherwise stated, parts are by weight, temperatures are in °C or at ambient temperature, and pressures are at or near atmospheric pressure.

[0130] Example 1: A bio-inert polymer (PEEK) was blended with an added bioactive calcium phosphate derivative (referred to as biphasic calcium phosphate (BCP)) via a dry blending process, followed by heat treatment via a twin-screw compounding process. First, the corresponding materials in powder form were weighed using a reverse-flow mixer to achieve a total composition ratio of 80 wt% polymer (80 g PEEK) and 20 wt% biphasic calcium phosphate (20 g BCP). The blended powder was then dried overnight at 80°C. After drying, the powder blend was processed in a twin-screw compounding machine with a temperature distribution between 250°C and 410°C. The resulting extrudate was then drawn into composite filaments and collected for melt-filament manufacturing.

[0131] Example 2: The composite filament of Example 1 was fabricated using the following method. A 3NTR A4v3 fuse fabrication printer was used to print PEEK + 20% BCP constructs. The constructs were printed using a nozzle temperature of 410°C, a print bed temperature of 135°C, and a print chamber temperature of 75°C. The first layer of the construct was printed with a thickness of 0.4 mm, while the remainder of the part was printed with a layer height of 0.1 mm. A raft was used for each print to prevent warping and to better adhere to the build plate. This procedure was performed to fabricate all test samples, where the variation existed only in the geometry of the selected aperture.

[0132] Example 3: As Figure 23 As described, fabricated samples of the blended composites from Examples 1 and 2 were exposed to static loads to measure the pull-out force after fixation to the synthetic bone with poly(methyl methacrylate) (PMMA) bone cement until a pull-out force was reached that would separate the sample from the PMMA / synthetic bone construct. The PMMA used was Stryker Simplex P, mixed in a vacuum at 20°C, with cement added after approximately 5 minutes. Compaction of the test constructs was performed using a surgical hammer and manual pressure to position the implant. After a 1-hour placement period, the implant construct was secured to a hydraulic actuator using a ½” stud on an MTS Mini Bionix tensile testing instrument. The synthetic bone construct was then clamped to the underside of the test area using a vise jaw. Testing was conducted at a constant displacement rate of 0.008 mm / s and a data sampling rate of 100 Hz until the load reached 10% of the peak load considered as failure. The data showed that samples with small pores and gradient porosity exhibited higher pull-out forces, thus providing better anchoring than samples without pores and those with large pores. The sample with gradient porosity demonstrated the best anchoring performance.

[0133] Example 4: Figure 24As depicted in the embodiments above, both non-porous and porous bone interface constructs were printed, and after distal fixation to epoxy resin, the proximal end of the implant was exposed to static load to measure the load required for implant failure in a bending environment. The implant was potted in a fixation device filled with two portions of epoxy resin (measured from the bottom flat surface of the implant condyle to the top of the resin-filled fixation device, with an embedment height of 25 mm). The potted implants were placed in an oven at 40°C for one hour, removed from the oven, and allowed to stand at room temperature for another hour to allow the resin to fully cure. The samples were then tested under compression conditions using an Instron 3366B dual-column frame. Each implant was placed between two compression plates, with the top plate sliding along the top surface of the implant condyle. Compression tests were then performed until failure. Compared to the non-porous bone interface, the porous bone interface showed that it retained a higher load and exhibited greater elongation before failure.

[0134] Example 5: Figure 21a As described in the paper, thermogravimetric analysis and energy-dispersive X-ray spectroscopy (EDAX) were used to quantify the weight percentage of the bioactive additive (biphasic calcium phosphate) in the composite filament. Approximately 25 mg of sample material was placed in a TGA Q500 under air atmosphere and exposed to the following temperature distribution: equilibration at 25 °C for at least 5 min, followed by ramping to 900 °C at 10 °C / min and then isothermal holding for 5 min. The reported residual mass was taken as the amount of bioactive additive in the composite. EDAX results were collected using a Hitachi TM3030 benchtop SEM with an accelerating voltage of 15 kV. The amount of biphasic calcium phosphate was also verified using the relative amounts of the chemical composition of carbon, oxygen, calcium, and phosphate. Figure 21c ).

Claims

1. A method for preparing a polymer-based knee implant, the polymer-based knee implant comprising an articular surface and a bone / implant interface; wherein the bone / implant interface is porous; and wherein the implant has a polymer material composed of a PAEK class, preferably PEEK, PEKK, or PEKEKK. The porous bone / implant interface has a pore size of 0.2 mm to 5 mm. The bone / implant interface contains bioactive additives. The bioactive additive mentioned above is a calcium phosphate derivative. The calcium phosphate derivative therein is biphasic calcium phosphate. The biphasic calcium phosphate is contained in the polymer material, and The bone / implant interface contains gradient porosity. The preparation is carried out by additive manufacturing after blending a bio-inert polymer with a bioactive additive to form a blend material.

2. The method according to claim 1, wherein the porous bone / implant interface preferably has a pore size of 0.3 mm to 1 mm.

3. The method according to claim 1, wherein the gradient porosity is a mixture of small pores and large pores.

4. The method of claim 1, wherein one of the pore layers exists beneath a series of second, different pore layers.

5. The method of claim 1, wherein the implant further comprises a fixation stud.

6. The method of claim 1, comprising one or more components, wherein at least one component of the implant comprises a bio-inert polymer.

7. The method of claim 6, wherein one or more components comprise a bio-inert polymer, and wherein the joint surface comprises a wear-resistant additive.

8. The method according to claim 7, wherein the wear-resistant additive is carbon, glass, polymer wear-resistant additive, ceramic wear-resistant additive, metal wear-resistant additive, or any combination or mixture thereof.

9. The method of claim 1, wherein one or more components of the implant comprise a bio-inert polymer and a bioactive additive, wherein the joint surface comprises a wear-resistant additive, and wherein the bone / implant interface is porous.

10. The method of claim 1, wherein the blend is manufactured by compounding the blended material into filaments using a twin-screw melt.

11. The method of claim 10, wherein the filament has a diameter of 1.5 mm to 3.25 mm.

12. The method of claim 10, wherein the filament contains up to about 20% by weight of the bioactive additive.

13. The method of claim 1, wherein the implant is printed via additive manufacturing at a printhead temperature of 380°C to 440°C.

14. The method of claim 1, wherein the implant is printed via additive manufacturing at a printing speed of 10 mm / sec to 40 mm / sec.

15. The method according to any one of the preceding claims, wherein the implant is subjected to thermal annealing.